|
- Treatment of Pelvic Inflammatory Disease - Medscape
Expert Rev Anti Infect Ther 2011;9(1):61-70 Pelvic inflammatory disease (PID) presents as a spectrum of infection-induced inflammation of the upper genital tract that includes endometritis
- Oral Norfloxacin vs Intravenous Ceftriaxone for the . . . - Medscape
David A Johnson, MD, provides clinical commentary on a recent article in Gastroenterology on the efficacy of norfloxacin vs ceftriaxone for prevention of infections in cirrhotics with GI bleeding
- Treatment of Pelvic Inflammatory Disease - Page 7 - Medscape
Ceftriaxone 250 mg intramuscularly in a single dose is our second choice owing to the fact that, unlike cefoxitin, it does not require the addition of oral probenecid
- Clinical Management of Early Syphilis - Page 5 - Medscape
Ceftriaxone overcame many of these obstacles, namely its long half-life that allows for daily dosing
- Ceftriaxone and Calcium Therapy in Adult Critical Care Patients - Medscape
Ceftriaxone is an important agent for clinical use in meningitis, severe community-acquired pneumonia, and intraabdominal infection
- Treatment of Pelvic Inflammatory Disease - Page 8 - Medscape
A combination of parenteral ceftriaxone and metronidazole or clindamycin provides this coverage It is unclear how long therapy need continue but most studies (Box 8) and the CDC recommendations
- UTI in Primary Care: New Guidelines - Medscape
Ceftriaxone is recommended for first-line therapy for patients who require intravenous treatment People often forget that we can do a lot to prevent UTIs, particularly among women with recurrent
- Diagnosis and Treatment of Pelvic Inflammatory Disease
CDC guidelines recommend outpatient treatment of PID with ofloxacin, levofloxacin, ceftriaxone plus doxycycline or cefoxitin and probenecid plus doxycycline; all with optional metronidazole for
|
|
|